Latest / Breaking News To Trading Moves
Teva Pharmaceutical: The Pivot to Growth Strategy Analysis
Teva previews “Pivot to Growth” at the J.P. Morgan Healthcare Conference
Teva ($TEVA) said CEO Richard Francis will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 (8:15am PT). Teva plans to discuss:
* Progress on its “Pivot to Growth” strategy (generics cash flow funding innovation)
* Growth drivers from key brands AUSTEDO, AJOVY, and UZEDY
* Pipeline focus (including olanzapine LAI, DARI (ICS/SABA), duvakitug (anti-TL1A), emrusolmin, anti-IL-15)
* Expected 2025 performance and a forward-looking outlook for 2026 and beyond, including disciplined capital…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.